Hematopoietic stem cells for treatment of chronic inflammatory demyelinating polyneuropathy

The aim of this study is to assess the efficacy of high-dose cyclophosphamide and anti-thymocyte globulin treatment, followed by autologous hematopoietic stem cell transplantation, in blunting the progression of chronic inflammatory demyelinating polyneuropathy (CIPD).